Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Dorocubicel by ExCellThera for Blood Cancer: Likelihood of Approval
Dorocubicel is under clinical development by ExCellThera and currently in Phase II for Blood Cancer. According to GlobalData, Phase II...
Dorocubicel by ExCellThera for Myelodysplastic Syndrome: Likelihood of Approval
Dorocubicel is under clinical development by ExCellThera and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase II...
ECT-001 by ExCellThera for Myelodysplastic Syndrome: Likelihood of Approval
ECT-001 is under clinical development by ExCellThera and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase II...